C.H. Robinson Worldwide
CHRW
135.18
+0.13
+0.10%
C.H. Robinson Worldwide
US · CHRW
#1021 by market cap
Listed 1970
135.18
+0.13
+0.10%
Live - 5344 symbols - heartbeat 115s ago
· 2026-10-08 05:53
Pre-market
133.99
-0.88%
After-hours
135.18
0.00%
Overnight
135.07
-0.08%
- Market cap
- 15.77B
- P/E (TTM)i
- 25.80
- P/Bi
- 9.69
- EPSi
- 4.83
- Div yieldi
- 1.86%
- 52W posi
- 15%
Reader sentiment
Are you bullish or bearish on CHRW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.58, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -8.42% YoY
Margins
- Gross margin
- 8.37%
- Operating margin
- 4.90%
- Net margin
- 3.62%
Key ratios & quality
- Enterprise valuei
- 16.77B
- Altman Z-Scorei
- 8.58
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.63B | 15.31B | 16.21B | 23.10B | 24.70B | 17.60B | 17.72B | 16.23B |
| Gross profit | 1.36B | 1.29B | 1.17B | 1.61B | 1.87B | 1.14B | 1.31B | 1.36B |
| Selling & admin expenses | 449.61M | 497.81M | 496.12M | 526.37M | 603.42M | 624.27M | 639.62M | 564.29M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 912.08M | 789.98M | 673.27M | 1.08B | 1.27B | 514.61M | 669.14M | 794.96M |
| Pretax profit | 880.27M | 742.26M | 628.33M | 1.02B | 1.17B | 409.19M | 579.20M | 722.46M |
| Tax | 215.77M | 165.29M | 121.91M | 178.05M | 226.24M | 84.06M | 113.51M | 135.38M |
| Net profit | 664.51M | 576.97M | 506.42M | 844.25M | 940.52M | 325.13M | 465.69M | 587.08M |
| Basic EPS | 5 | 4 | 4 | 6 | 7 | 3 | 4 | 5 |
| Diluted EPS | 4.73 | 4.19 | 3.72 | 6.31 | 7.40 | 2.72 | 3.86 | 4.83 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.05B | 4.14B | 4.14B | 3.91B | 4.01B | 4.93B |
| Gross profit | 324.54M | 357.91M | 356.78M | 320.03M | 307.77M | 399.49M |
| Selling & admin expenses | 147.68M | 141.99M | 135.94M | 138.68M | 132.08M | 143.75M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 176.85M | 215.92M | 220.84M | 181.35M | 175.69M | 255.74M |
| Pretax profit | 156.80M | 193.89M | 205.23M | 166.53M | 166.67M | 237.87M |
| Tax | 21.50M | 41.42M | 42.25M | 30.21M | 19.44M | 51.08M |
| Net profit | 135.30M | 152.47M | 162.99M | 136.32M | 147.23M | 186.79M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 1.11 | 1.26 | 1.34 | 1.12 | 1.22 | 1.56 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.75B | 2.64B | 2.94B | 4.80B | 3.59B | 2.88B | 2.97B | 2.80B |
| Cash & ST investments | 378.62M | 447.86M | 243.80M | 257.41M | 217.48M | 145.52M | 145.76M | 160.87M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 4.43B | 4.64B | 5.14B | 7.03B | 5.95B | 5.23B | 5.30B | 5.06B |
| Total current liabilities | 1.43B | 1.56B | 1.84B | 3.33B | 3.32B | 2.05B | 2.32B | 1.83B |
| Short-term debt | 5.00M | 204.17M | 66.17M | 591.31M | 1.13B | 234.45M | 528.63M | 72.18M |
| Long-term debt | 1.34B | 1.09B | 1.09B | 1.39B | 920.05M | 1.42B | 921.86M | 1.09B |
| Total liabilities | 2,832,325,000.00 | 2,970,330,000.00 | 3,264,325,000.00 | 5,006,178,000.00 | 4,601,142,000.00 | 3,806,583,000.00 | 3,575,875,000.00 | 3,212,734,000.00 |
| Total equity | 1.60B | 1.67B | 1.88B | 2.02B | 1.35B | 1.42B | 1.72B | 1.85B |
| Retained earnings | 3.85B | 4.14B | 4.37B | 4.94B | 5.59B | 5.62B | 5.79B | 6.07B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.92B | 3.01B | 2.99B | 2.80B | 3.01B | 3.56B |
| Cash & ST investments | 129.94M | 155.99M | 136.84M | 160.87M | 159.67M | 154.59M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.23B | 5.32B | 5.23B | 5.06B | 5.24B | 5.84B |
| Total current liabilities | 2.26B | 2.30B | 1.88B | 1.83B | 1.90B | 2.25B |
| Short-term debt | 537.79M | 504.61M | 72.20M | 72.18M | 71.66M | 70.65M |
| Long-term debt | 922.09M | 922.32M | 1.18B | 1.09B | 1.34B | 1.69B |
| Total liabilities | 3,491,389,000.00 | 3,537,524,000.00 | 3,370,813,000.00 | 3,212,734,000.00 | 3,531,298,000.00 | 4,215,816,000.00 |
| Total equity | 1.73B | 1.78B | 1.86B | 1.85B | 1.70B | 1.63B |
| Retained earnings | 5.85B | 5.92B | 6.01B | 6.07B | 6.14B | 6.25B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 792.90M | 835.42M | 499.19M | 94.96M | 1.65B | 731.95M | 509.08M | 914.52M |
| Depreciation & amortization | 96.73M | 100.45M | 101.73M | 91.26M | 92.78M | 98.99M | 97.16M | 102.82M |
| Free cash flow | 729.03M | 764.95M | 445.18M | 24.03M | 1.52B | 647.84M | 434.80M | 843.98M |
| Dividends paid | -265.22M | -277.79M | -209.96M | -277.32M | -285.32M | -291.57M | -294.77M | -301.38M |
| Stock buybacks / issuance | -300.99M | -309.44M | -177.51M | -581.76M | -1.46B | -63.88M | 0 | -354.65M |
| Ending cash balance | 378.62M | 447.86M | 243.80M | 257.41M | 217.48M | 145.52M | 145.76M | 160.87M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 106.53M | 227.13M | 275.45M | 305.41M | 68.60M | 35.90M |
| Depreciation & amortization | 25.64M | 24.87M | 25.83M | 26.48M | 24.85M | 22.57M |
| Free cash flow | 90.45M | 206.97M | 256.83M | 289.73M | 53.58M | 17.66M |
| Dividends paid | -77.49M | -74.87M | -74.70M | -74.32M | -79.03M | -75.27M |
| Stock buybacks / issuance | -47.70M | -81.07M | -111.49M | -114.40M | -212.66M | -219.52M |
| Ending cash balance | 129.94M | 155.99M | 136.84M | 160.87M | 159.67M | 154.59M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 43.99 | 35.33 | 28.53 | 43.27 | 55.73 | 23.46 | 29.65 | 32.91 |
| ROA %i | 15.34 | 12.72 | 10.35 | 13.87 | 14.49 | 5.82 | 8.85 | 11.34 |
| ROIC %i | 23.61 | 19.91 | 16.61 | 23.65 | 25.65 | 11.54 | 15.74 | 19.27 |
| 5-year avg ROE %i | 43.18 | 41.20 | 37.62 | 37.75 | 41.37 | 37.26 | 36.13 | 37.01 |
| EBIT margin %i | 5.48 | 5.16 | 4.15 | 4.68 | 5.13 | 2.92 | 3.78 | 4.90 |
| FCF / sales %i | 4.38 | 5.00 | 2.75 | 0.10 | 6.16 | 3.68 | 2.45 | 5.20 |
| Current ratioi | 1.92 | 1.70 | 1.60 | 1.44 | 1.08 | 1.40 | 1.28 | 1.53 |
| Quick ratioi | 1.88 | 1.64 | 1.57 | 1.41 | 1.04 | 1.32 | 1.17 | 1.46 |
| Debt / assetsi | 30.41 | 33.53 | 27.76 | 31.68 | 39.65 | 37.37 | 32.86 | 27.59 |
| LT debt / equityi | 84.09 | 80.92 | 72.44 | 80.86 | 91.16 | 121.10 | 70.41 | 71.69 |
| Interest coveragei | 28.67 | 16.55 | 14.98 | 18.09 | 12.67 | 4.88 | 7.44 | 10.96 |
| Revenue CAGR (3Y) %i | 7.26 | 5.21 | 2.91 | 11.58 | 17.28 | 2.78 | -8.45 | -13.05 |
| Net income CAGR (3Y) %i | 9.24 | 3.97 | 0.10 | 8.31 | 17.69 | -13.73 | -17.99 | -14.54 |
| FCF CAGR (3Y) %i | 2.67 | 20.43 | 10.94 | -67.94 | 25.77 | 13.32 | 162.52 | -17.84 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 32.11 | 32.43 | 34.32 | 32.91 | 34.84 | 37.12 |
| ROA %i | 9.50 | 9.86 | 11.07 | 11.34 | 11.45 | 11.34 |
| ROIC %i | 16.73 | 15.33 | 19.10 | 19.27 | 17.59 | 17.90 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.14 | 4.45 | 4.83 | 4.90 | 4.90 | 4.90 |
| FCF / sales %i | 3.35 | 3.77 | 4.89 | 5.20 | 4.98 | 3.63 |
| Current ratioi | 1.29 | 1.31 | 1.59 | 1.53 | 1.59 | 1.58 |
| Quick ratioi | 1.24 | 1.26 | 1.52 | 1.46 | 1.52 | 1.53 |
| Debt / assetsi | 33.08 | 31.79 | 28.74 | 27.59 | 31.41 | 33.76 |
| LT debt / equityi | 68.66 | 66.53 | 77.02 | 71.69 | 92.30 | 116.85 |
| Interest coveragei | 7.71 | -- | 10.92 | 10.96 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- North American Surface Transportation (NAST) is the largest reported line at 72.83% of revenue, across 3 reported segments.
- The next-largest line, Global Forwarding, is a distant second at 18.17% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
North American Surface Transportation (NAST)72.83%
Global Forwarding18.17%
Other revenues9.00%
Quote time 2026-10-08 05:53:30 · For reference only, not investment advice and not tailored to your situation.